David Rageot

539 citations
18 papers · 398 indexed · h-index 10

David Rageot

16 papers receiving 392 citations

Peers

David Rageot
Comparison fields: 5 of 56
  • Transplantation 145
  • Nephrology 52
  • Pathology and Forensic Medicine 93
  • Immunology 108
  • Oncology 135
Replace Joan Morote with:
Joan Morote Spain
S. Michelle Shiller United States
Weiguo Sui China
Francesco Lasorsa Italy
Maria Vaysberg United States
Jeroen Depreeuw Belgium
Jérôme Alexandre France
Claudio Losio Italy
Lola Luo United States
Akitsugu Ojima Japan
David Rageot relative to Joan Morote Spain Joan Morote's profile →
Citations per field
00.5×4.7×
Joan Morote · 1×
Citations per year

Countries citing papers authored by David Rageot

Since Specialization
Citations

This map shows the geographic impact of David Rageot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rageot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rageot more than expected).

Fields of papers citing papers by David Rageot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rageot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rageot. The network helps show where David Rageot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Rageot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Rageot Line = papers co-authored together David Rageot links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 20253
2 20251
3 20255
4 20241
5 20240
6 20243
7 20231
8 202179
9 202118
10 20199
11 201410
12 20060
13 200540
14 200435
15 2003112
16 200324
17 200312
18 200245

About David Rageot

David Rageot is a scholar working on Transplantation, Nephrology, Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 18 papers that have together received 398 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), Colorectal Cancer Screening and Detection (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Renal Diseases and Glomerulopathies (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Transplantation (145 citations), Nephrology (52 citations), Pathology and Forensic Medicine (93 citations), Immunology (108 citations) and Oncology (135 citations). David Rageot has collaborated with scholars based in France, Netherlands and Italy. Frequent co-authors include Laurent Martin, Christiane Mousson, F. Guignier, Gérard Rifle, E Justrabo, Anne‐Marie Bouvier, Jean Faivre, Caroline Chapusot, Tibor Ponnelle and F Piard. Their work appears in journals such as EBioMedicine, Transplantation, Scientific Reports, British Journal of Cancer and The American Journal of Surgical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026